New Delhi, July 21 (IANS) India has approved its first vaccine for the prevention of dengue, a major step in strengthening the country’s response to one of its fastest-growing mosquito-borne diseases, an official statement said on Tuesday.The Central Drugs Standard Control Organisation (CDSCO) — under the Ministry of Health and Family Welfare — has granted marketing authorisation for Qdenga, a live, attenuated tetravalent dengue vaccine developed by Takeda GmbH, Germany. The vaccine will be im…
Latest QDENGA News & Updates
New Delhi, July 20 (IANS) India has approved its first dengue vaccine, with the Drug Controller General of India (DCGI) granting market authorisation to Takeda Biopharmaceuticals India’s QDENGA, marking a significant milestone in the country’s efforts to combat one of its most widespread mosquito-borne diseases, it was announced on Monday.The vaccine has been approved for individuals aged between 4 and 60 years and can be administered irrespective of whether a person has previously been infected…